Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stranger in a strange land.

Joan S Hunt1

  • 1Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA. jhunt@kumc.edu

Immunological Reviews
|September 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms.

Journal of immunology (Baltimore, Md. : 1950)·2019
Same author

Transcriptional regulation of VEGF-A by the unfolded protein response pathway.

PloS one·2010
Same author

Investigation of an antibody reported to identify leukocyte immunoglobulin-like receptors (LILRB2) on placental vascular smooth muscle.

Placenta·2009
Same author

Placenta.

The International journal of developmental biology·2009
Same author

Immunoregulatory molecules in human placentas: potential for diverse roles in pregnancy.

The International journal of developmental biology·2009
Same author

HLA-G: a human pregnancy-related immunomodulator.

Current opinion in pharmacology·2009
Same journal

Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.

Immunological reviews·2026
Same journal

Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure.

Immunological reviews·2026
Same journal

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity.

Immunological reviews·2026
Same journal

Tissue-Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation.

Immunological reviews·2026
Same journal

Rethinking Immunity in Tissues: The Biology of Tertiary Lymphoid Structures.

Immunological reviews·2026
Same journal

Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity.

Immunological reviews·2026
See all related articles

Maternal immune tolerance during pregnancy is achieved through complex mechanisms. Soluble human leukocyte antigen-G (sHLA-G) isoforms, produced via alternative splicing, play a key role in establishing immune privilege by suppressing maternal immune responses to the fetus.

Area of Science:

  • Reproductive immunology
  • Maternal-fetal tolerance
  • Immunogenetics

Background:

  • Mammalian pregnancy involves a genetically dissimilar mother and fetus, necessitating immune evasion strategies.
  • Uteroplacental immune privilege is established through soluble immunosuppressive factors and regulated placental cell surface molecules.
  • Trophoblast cells, unique to pregnancy, interact directly with maternal blood and exhibit restricted expression of major histocompatibility complex (MHC) molecules.

Purpose of the Study:

  • To investigate the expression, regulation, and function of soluble isoforms of human leukocyte antigen-G (HLA-G).
  • To elucidate the role of soluble HLA-G in maternal-fetal immune tolerance.
  • To understand the contribution of soluble HLA-G to uteroplacental immune privilege.

Main Methods:

Related Experiment Videos

  • Analysis of HLA-G gene expression and alternative splicing.
  • Detection and quantification of soluble HLA-G isoforms in maternal circulation and uterine tissues.
  • Functional assays to assess the immunosuppressive properties of soluble HLA-G.

Main Results:

  • The single HLA-G gene produces multiple soluble isoforms through alternative splicing.
  • These soluble HLA-G isoforms are present at high levels in the pregnant uterus and maternal blood.
  • Soluble HLA-G proteins exhibit immunosuppressive properties, contributing to local immune privilege.

Conclusions:

  • Soluble HLA-G isoforms represent a critical component of the maternal immune tolerance system during pregnancy.
  • These molecules facilitate the establishment of a tolerogenic environment, preventing immune rejection of the semi-allogeneic fetus.
  • Soluble HLA-G may offer a unique therapeutic target for managing pregnancy complications related to immune maladaptation.